Delivery Order SPE2DR25D1106-SPE2DR26FJP0J
Award Date 2/24/26
Potential Completion Date 2/25/26
Potential Value $285K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 13, 2026, with a ceiling value of $16,396.07 for supply of NURTEC ODT 75 MG Tablet 8S. Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 17, 2026. No set-aside was used. AmerisourceBergen Drug Corp operates as a division of Cencora, Inc. and holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to...
- <p>The Defense Logistics Agency issued a $45,828.94 delivery order to Amerisourcebergen Drug Corp on February 2, 2026, for supply of NURTEC ODT 75 mg tablets (8-count).</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 3, 2026. The order was issued under firm fixed-price pricing with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc.</p>
- The Defense Logistics Agency issued a $19,834.76 delivery order to AmerisourceBergen Drug Corp on February 20, 2026, for NURTEC ODT 75 mg tablets (8 count). Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 23, 2026. No set-aside was used. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. and serves as a critical pharmaceutical distributor for federal medical procurement, particularly for military and...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 11, 2026, with a ceiling value of $14,864.04 for supply of NURTEC ODT 75 mg tablets (8-count). Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 12, 2026. No set-aside was used. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. and supplies pharmaceutical products under DLA Troop Support Medical indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,655.81 to Amerisourcebergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count) on January 27, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters. This delivery order will be completed by January 28, 2026. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,161.20 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on February 4, 2026, with a completion date of February 5, 2026. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $89,553.56 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on January 30, 2026, with an ultimate completion date of February 2, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical supplier to federal medical...
- The Defense Logistics Agency issued a $36,094.74 delivery order to Amerisourcebergen Drug Corp on February 12, 2026, for NURTEC ODT 75 mg tablets (8-count units). Place of performance is Conshohocken, PA. The order ceiling value is $36,094.74 with an ultimate completion date of February 13, 2026. Pricing is firm fixed price. The delivery order was issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical valued at $999,999,999.00 through December 2026, supporting...
- The Defense Logistics Agency awarded a delivery order valued at $5,842.84 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count) on January 26, 2026, with an ultimate completion date of January 27, 2026. This is a firm fixed-price, non-set-aside contract performed out of the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor in the...
- The Defense Logistics Agency awarded a delivery order valued at $10,676.74 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on January 16, 2026, with completion targeted for January 20, 2026. This firm fixed-price, competitively awarded contract (no set-aside) is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJP0JDelivery Order
The Defense Logistics Agency issued a $284,524.98 delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for NURTEC ODT 75 mg tablets (8-count). Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 25, 2026, and carries firm fixed pricing with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs. The company holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which serves as the parent vehicle for supplying pharmaceutical products and medical supplies to support military healthcare systems globally.
Generated 5/25/26, 10:01 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $284.5k | 2/23/26 |